FHL1 and age-related macular degeneration: The finding that the Y402H polymorphism has no effect on systemic levels or activity of FH/FHL-1 [176] is consistent with AMD being a disease of local complement dysregulation, e.g. at the interface of the RPE and Bruch’s membrane, which is where the pathology initially develops.